Discussion about this post

User's avatar
Betsy McDonel Herr, Ph.D.'s avatar

Attempts to ask these questions of various datasets are vitally important and you have found a really great resource to apply your questions, and to replicate other's findings. It is a lot of good effort. For which many are grateful, as there is clearly a danger signal for one or more shots.

Here are my impressions:

With all of these analyses published on a variety of Substacks, when trying to look at number of jabs, mortality and correlations, there is always the problem of sampling from the population without replacement. In other words, once you have killed off a number of people with the first shot, it is a different sample for the second shot. Some of the most vulnerable were taken out. Some of the people who took one shot and decided against the second might have had a bad reaction and decided, "whoa no more for me." Or maybe they started to see bad news trickle in. For example, my sister fortunately decided against the shot after seeing three people in her social and work circle promptly pass away after their one or two shots. At some point they stopped refrigerating the shots to be so cold. Other groups have verified bad lots and serious problems and variation in manufacturing. The same thing then happens again between shot 2 and 3 and 3 and 4 to further winnow and change the nature of the remaining sample. This would attenuate the correlation a bit for shot two, and then even more for shot three as you have now taken out more people from the same population who potentially had highest vulnerability to these shots if in fact that is a thing.

Ideally you want three separate populations to test, randomized or well-matched to compare separately 1, 2 and 3 shot schemes. Given the sampling without replacement and the other variables adding possible variation to the outcome including inaccuracies in reporting of shots it is remarkable that these signals are still so strong, as death is the dependent variable. The findings so far still supports the recommendation that all shots should be stopped immediately and all data sifted through.

Of course, all this work should have been done by pharma prior to FDA authorization, a randomized set of trials.

So there may be sophisticated techniques to help overcome, post hoc, these biases in the sampling. I think Matthew Crawford might have referred to progressive bias in sampling as survivor bias. There are also regression techniques in the area of survival analysis that might apply--who survives the shot schemes the longest, what makes them different using independent variables related to your overall theory and/or supplied by critics?

A comprehensive analysis with these sorts of multiple data sets across populations and the work of many thoughtful analysts is due--maybe as a coordinated roundtable with steering committee to plan and then conduct analyses. Also, if someone has access to graduate students in statistics or population public health data analysis it seems like this type of work would be ideal to that setting, as the project would be a layered, iterative, programmatic and complex set of questions. Such could be the focus of a master's or dissertation thesis with oversight of a large and qualified committee, including outside members who have been active on these questions and datasets. (I've been a member of about 2 dozen dissertation oversight committees and 4 master's theses).

Who wouldn't want "The Naked Emperor" as one of a committee to sign off on their thesis?

Expand full comment
UK refugee's avatar

I'd recommend you make this article immediately free to all (currently has 7 day paywall which is fine on other articles for sure) and ask people to circulate on Social Media asking for evidence and analysis for support or refutation.

Expand full comment
14 more comments...

No posts

Ready for more?